The New York Times | Our Drug Supply Is Sick. How Can We Fix It?

The New York Times released an article titled "Our Drug Supply Is Sick. How Can We Fix It?" Farah Stockman discusses how the American healthcare system is built upon the widely disputed concept that generic drugs are considered equal to one another and the name brand. The piece recognizes Valisure as a leader attempting to address these issues and highlights the opportunities for change through action by large health systems.

View the full article via The New York Times here.

The New York Times | Our Drug Supply Is Sick. How Can We Fix It?

April 7, 2022

The New York Times released an article titled "Our Drug Supply Is Sick. How Can We Fix It?" Farah Stockman discusses how the American healthcare system is built upon the widely disputed concept that generic drugs are considered equal to one another and the name brand. The piece recognizes Valisure as a leader attempting to address these issues and highlights the opportunities for change through action by large health systems.

View the full article via The New York Times here.

The New York Times | Our Drug Supply Is Sick. How Can We Fix It?

The New York Times released an article titled "Our Drug Supply Is Sick. How Can We Fix It?" Farah Stockman discusses how the American healthcare system is built upon the widely disputed concept that generic drugs are considered equal to one another and the name brand. The piece recognizes Valisure as a leader attempting to address these issues and highlights the opportunities for change through action by large health systems.

View the full article via The New York Times here.

The New York Times released an article titled "Our Drug Supply Is Sick. How Can We Fix It?" Farah Stockman discusses how the American healthcare system is built upon the widely disputed concept that generic drugs are considered equal to one another and the name brand. The piece recognizes Valisure as a leader attempting to address these issues and highlights the opportunities for change through action by large health systems.

View the full article via The New York Times here.

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.